| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/10/2006 | WO2006083019A1 AMYLOID β PROTEIN AGGREGATION INHIBITOR, DIAGNOSTIC AGENT FOR ABNORMALITY OF AMYLOID β PROTEIN, AND DIAGNOSTIC KIT FOR ABNORMALITY OF AMYLOID β PROTEIN |
| 08/10/2006 | WO2006083005A1 Fused pyrimidine derivative and used thereof |
| 08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082728A1 Transdermal absorption patch |
| 08/10/2006 | WO2006082456A1 Cyclohexylamides as dopamine d3 , d2 and 5ht1a antagonists |
| 08/10/2006 | WO2006082409A2 Tricyclic cytoprotective compounds |
| 08/10/2006 | WO2006082354A1 Azacyclic compounds as inhibitors of sensory neurone specific channels ( sns ) |
| 08/10/2006 | WO2006082071A1 Method for producing a drug extract that contains hydroxystilbene |
| 08/10/2006 | WO2006082068A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
| 08/10/2006 | WO2006082046A1 Use of s-clenbuterol |
| 08/10/2006 | WO2006082002A1 Imidazole derivatives |
| 08/10/2006 | WO2006081808A1 Pharmaceutical substance for the treatment of multiple sclerosis and aids |
| 08/10/2006 | WO2006081616A1 Classes of compounds that interact with integrins |
| 08/10/2006 | WO2006069276A3 TRICYCLIC ō-OPIOID MODULATORS |
| 08/10/2006 | WO2006067565A3 Truncated gabab receptor and methods of use thereof |
| 08/10/2006 | WO2006066121A3 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 08/10/2006 | WO2006058007A3 Jnk inhibitors for treatment of cns injury |
| 08/10/2006 | WO2006052496A3 Compound useful for the treatment or prevention of cognitive disorders associated with diabetes and the use thereof |
| 08/10/2006 | WO2006047671A3 4-aminotetracyclines and methods of use thereof |
| 08/10/2006 | WO2006024947A3 Methods and materials relating to enhanced production of dopamine neurons |
| 08/10/2006 | WO2006018850A3 Compositions for treating amyloid associated diseases |
| 08/10/2006 | WO2005041856A3 Use of 2-thia-dibenzo[e, h]azulenes for the treatment and prevention of central nervous system diseases and disorders |
| 08/10/2006 | WO2004060381A8 Rabbit skin comprising biological active substance and its use |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060178516 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 08/10/2006 | US20060178515 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 08/10/2006 | US20060178438 Muscarinic agonists |
| 08/10/2006 | US20060178420 Indole derivatives as anti-inflammatory agents |
| 08/10/2006 | US20060178418 For therapy of asthma, bronchial asthma, chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohns disease, psoraisis, uticaria, adult vernal conjunctivitis, |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178401 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/10/2006 | US20060178379 Methods of treating patients suffering from movement disorders |
| 08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178371 7-amino-pyrrazolo[1,5-a]pyrimidine derivatives, useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178345 Substituted alcohols useful in treatment of Alzheimer's disease |
| 08/10/2006 | US20060178333 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof |
| 08/10/2006 | US20060178323 Methods for the treatment of chronic pain and compositions therefor |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
| 08/10/2006 | US20060177528 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent |
| 08/10/2006 | US20060177433 Treatment of alpha-galactosidase a deficiency |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | US20060177431 Inhibitors for continuous activation of calcineurin |
| 08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
| 08/10/2006 | DE102005005275A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression |
| 08/10/2006 | DE102005005270A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression |
| 08/10/2006 | DE102005004343A1 Behandlung von Phantomphänomenen Treatment of phantom phenomena |
| 08/10/2006 | CA2596993A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | CA2596973A1 Raf inhibitor compounds and methods |
| 08/10/2006 | CA2596854A1 Imidazole derivatives |
| 08/10/2006 | CA2596736A1 Tricyclic cytoprotective compounds |
| 08/10/2006 | CA2596594A1 Pulsatilla spp. extracts effective in brain function |
| 08/10/2006 | CA2596178A1 Method for producing a drug extract that contains hydroxystilbene |
| 08/10/2006 | CA2596171A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
| 08/10/2006 | CA2594845A1 Cyclohexylamides as dopamine d3 , d2 and 5ht1a antagonists |
| 08/10/2006 | CA2593857A1 Amino-pyridines as inhibitors of .beta.-secretase |
| 08/10/2006 | CA2593749A1 Classes of compounds that interact with integrins |
| 08/09/2006 | EP1688434A1 Antibody and use of the same |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688425A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688149A1 Paste formulations comprising silica |
| 08/09/2006 | EP1688137A1 SPM 927 for add-on therapy of schizophrenia |
| 08/09/2006 | EP1688036A1 Transgenic nonhuman mammal |
| 08/09/2006 | EP1687631A1 Methods for identifying compounds involved in the phosphoinositide-mediated signalling and use thereof in the manufacture of medicaments |
| 08/09/2006 | EP1687314A1 PREPARATION OF 1-AZA-2-OXA-DIBENZO [e,h] AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 08/09/2006 | EP1687306A1 Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 08/09/2006 | EP1687303A1 4-substituted imidazoles |
| 08/09/2006 | EP1687302A1 5-substituted imidazoles |
| 08/09/2006 | EP1687293A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 08/09/2006 | EP1687279A1 7- [4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics |
| 08/09/2006 | EP1687277A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/09/2006 | EP1687275A1 Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain |
| 08/09/2006 | EP1687259A1 Cyclopentyl derivates |
| 08/09/2006 | EP1687013A1 Drug |
| 08/09/2006 | EP1687005A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 08/09/2006 | EP1687003A1 (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol for treating anxiety |
| 08/09/2006 | EP1687001A2 Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disorders |
| 08/09/2006 | EP1687000A2 Use of cyclooxygenase-2 inhibitors for the treatment of depressive disorders |
| 08/09/2006 | EP1686989A1 Use of 1,2-diaza-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 08/09/2006 | EP1686984A1 Use of c-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders |
| 08/09/2006 | EP1572666B1 3h-quinazolin-4-one derivatives |
| 08/09/2006 | EP1560822B1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors |
| 08/09/2006 | EP1511748B1 8-fluorimidazo(1,2-a)pyridine derivatives as ligands for gaba receptors |
| 08/09/2006 | EP1478638B1 Purification of citalopram |
| 08/09/2006 | EP1456351B1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 08/09/2006 | EP1455779B1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 08/09/2006 | EP1453949B1 Production of cell suspensions |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1441730B1 Hydrazono-malonitriles |
| 08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
| 08/09/2006 | EP1354032B1 Gene regulation therapy involving ferritin |